FDA Inspection 1197718 — SSM-SLUH, Inc.

SSM-SLUH, Inc. — FEI 1972831

The FDA completed an inspection of SSM-SLUH, Inc. on Feb 17, 2023 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 17, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Saint Louis, MO (United States)

Citations

IDCFRDescription
430421 CFR 211.68(b)Written record not kept of program and validation data
440221 CFR 211.192Written record of investigation incomplete
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.